News | October 04, 2012

Multi-Leaf Collimator Increases Accuracy, Reduces Radio Therapy Dose at James Cook University Hospital

October 4, 2012 — Less than three months after beginning clinical use of their Elekta Agility 160-leaf multi-leaf collimator (MLC), physicians at The James Cook University Hospital in Middlesbrough, England, have achieved another benchmark – their first use of Agility to deliver radiation therapy employing Elekta's volumetric modulated arc therapy (VMAT). The ability to accelerate both beam shaping and beam delivery with Agility and VMAT cut 57 seconds off the beam delivery time for the first patient, a 61-year-old male with prostate cancer.

Using twice the number of leaves typical of many standard MLCs, Agility precisely sculpts delivered radiation to the distinctive contours of the tumor, while reducing the risk of exposure to healthy normal tissues. Agility also includes ultra-fast leaf movements – twice as fast as other MLCs commonly used in the industry. Agility complements rapid beam delivery techniques, such as VMAT, in which single or multiple radiation beams sweep in one or more uninterrupted arcs around the patient, reducing treatment times significantly.

On Aug. 8, the patient received his first treatment fraction, a single 200-degree VMAT arc, which took just 83 seconds to deliver. In comparison, a three-field 3-D conformal treatment would have taken 140 seconds (2:20 minutes) to deliver, demonstrating a 40.7 percent reduction in beam delivery time with Agility/VMAT. When factoring in image guidance, the total treatment timesavings with Agility/VMAT was 72 seconds (1:12 minutes).

"This was our first experience with VMAT and it went very well," said Christopher Walker, head of radiotherapy physics at The James Cook University Hospital. "The treatment speed not only reduces the likelihood that the patient will move and that the internal organs will shift position, but it also contributes to faster patient throughput, which is key. With Agility/VMAT we expect to be able to treat five patients per hour."

A new version of Monaco (v 3.20) was used to plan the first Agility/VMAT case. "We used PIVOTAL trial dose constraints, achieving good coverage of the target and optimal sparing of the rectum and bladder," Walker said. "It was a significant improvement over our previous 3-D conformal planning."

The image guidance technology on their Elekta Synergy treatment system also was critical for ensuring accuracy. "We wouldn't have done the treatment without the cone beam CT [computed tomography] on the Synergy system," he added. "Through image guidance we identified movement of the target volume before treatment delivery on the first day, which resulted in us re-planning the patient before subsequent treatments."

With the successful launch of Agility/VMAT at The James Cook University Hospital, clinicians there have begun treating a second prostate patient and a third is on the schedule. "We're now open for business as far as prostate VMAT is concerned," Walker said. "Looking ahead, we will be expanding out to other sites in the body over the next few months."

Agility is not available for sale or distribution in all markets.

For more information: www.elekta.com/agility

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init